Recall for Migraine Medicine That Could Be Contaminated

by | Aug 18, 2019 | Migraine | 0 comments

Pfizer Inc. issued a voluntary nationwide recall Wednesday for two lots of Relpax (eletriptan hydrobromide) 40-milligram tablets due to the potential contamination. The lots are AR5407 and CD4565.

Read more here.

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Pin It on Pinterest